Aversive memory formation in humans involves an amygdala-hippocampus phase code.
Manuela CostaDiego Lozano-SoldevillaAntonio Gil-NagelRafael ToledanoCarina R OehrnLukas KunzMar YebraCostantino Mendez-BertoloLennart Henning StieglitzJohannes SarntheinNikolai AxmacherStephan MorattiBryan A StrangePublished in: Nature communications (2022)
Memory for aversive events is central to survival but can become maladaptive in psychiatric disorders. Memory enhancement for emotional events is thought to depend on amygdala modulation of hippocampal activity. However, the neural dynamics of amygdala-hippocampal communication during emotional memory encoding remain unknown. Using simultaneous intracranial recordings from both structures in human patients, here we show that successful emotional memory encoding depends on the amygdala theta phase to which hippocampal gamma activity and neuronal firing couple. The phase difference between subsequently remembered vs. not-remembered emotional stimuli translates to a time period that enables lagged coherence between amygdala and downstream hippocampal gamma. These results reveal a mechanism whereby amygdala theta phase coordinates transient amygdala -hippocampal gamma coherence to facilitate aversive memory encoding. Pacing of lagged gamma coherence via amygdala theta phase may represent a general mechanism through which the amygdala relays emotional content to distant brain regions to modulate other aspects of cognition, such as attention and decision-making.
Keyphrases
- prefrontal cortex
- temporal lobe epilepsy
- functional connectivity
- working memory
- resting state
- cerebral ischemia
- decision making
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- stress induced
- lymph node
- subarachnoid hemorrhage
- transcranial magnetic stimulation
- ejection fraction
- brain injury
- genome wide
- heart failure
- gene expression
- peritoneal dialysis
- dna methylation
- cognitive impairment
- high frequency
- left ventricular
- atrial fibrillation
- induced pluripotent stem cells
- patient reported
- cardiac resynchronization therapy